{
  "id": 1306,
  "text": "A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .\n\n<question>: ",
  "ChatGPT_response_0": "根据您提供的数据，在IB至IIA期，新辅助化疗和放疗两组的5年疾病自由生存率分别为77.1%和64.3%，而在IIB期分别为56.2%和57.1%。这些数据显示在IB至IIA期，新辅助化疗组的生存率高于放疗组，符合预期；而在IIB期，两组的生存率接近，与预期有所不同。需要进一步了解患者特点和治疗方案，以更好地解释这些结果。",
  "query": "对于IB至IIA期，新辅助化疗和放疗两组的5年疾病自由生存率分别为77.1%和64.3%，而在IIB期分别为56.2%和57.1%（P值分别小于0.05和大于0.05），这些数据是否符合您的预期？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于IB至IIA期，新辅助化疗和放疗两组的5年疾病自由生存率分别为77.1%和64.3%，而在IIB期分别为56.2%和57.1%（P值分别小于0.05和大于0.05），这些数据是否符合您的预期？\n\n<reference text>: A 5-year DFS rate for the NACT arm and radiotherapy arm, respectively, of $7 7 .1 \\%$ and $6 4 .3 \\%$ in stages IB-IIA $\\mathrm { ( p < 0 .0 5 ) }$ ), $5 6 .2 \\%$ and $5 7 .1 \\%$ in stage IIB $\\mathrm { ( p > 0 .\n\n<reply>: ",
  "response": "根据您提供的数据，在IB至IIA期，新辅助化疗和放疗两组的5年疾病自由生存率分别为77.1%和64.3%，而在IIB期分别为56.2%和57.1%。这些数据显示在IB至IIA期，新辅助化疗组的生存率高于放疗组，符合预期；而在IIB期，两组的生存率接近，与预期有所不同。需要进一步了解患者特点和治疗方案，以更好地解释这些结果。"
}